299 related articles for article (PubMed ID: 26786772)
1. A molecular arms race between host innate antiviral response and emerging human coronaviruses.
Wong LY; Lui PY; Jin DY
Virol Sin; 2016 Feb; 31(1):12-23. PubMed ID: 26786772
[TBL] [Abstract][Full Text] [Related]
2. Pathogenic human coronavirus infections: causes and consequences of cytokine storm and immunopathology.
Channappanavar R; Perlman S
Semin Immunopathol; 2017 Jul; 39(5):529-539. PubMed ID: 28466096
[TBL] [Abstract][Full Text] [Related]
3. Induction of the Antiviral Immune Response and Its Circumvention by Coronaviruses.
Liu P; Hong Y; Yang B; Shrestha P; Sajjad N; Chen JL
Viruses; 2020 Sep; 12(9):. PubMed ID: 32961897
[TBL] [Abstract][Full Text] [Related]
4. Middle East Respiratory Syndrome Coronavirus NS4b Protein Inhibits Host RNase L Activation.
Thornbrough JM; Jha BK; Yount B; Goldstein SA; Li Y; Elliott R; Sims AC; Baric RS; Silverman RH; Weiss SR
mBio; 2016 Mar; 7(2):e00258. PubMed ID: 27025250
[TBL] [Abstract][Full Text] [Related]
5. Severe acute respiratory syndrome vs. the Middle East respiratory syndrome.
Hui DS; Memish ZA; Zumla A
Curr Opin Pulm Med; 2014 May; 20(3):233-41. PubMed ID: 24626235
[TBL] [Abstract][Full Text] [Related]
6. Middle east respiratory syndrome coronavirus 4a protein is a double-stranded RNA-binding protein that suppresses PACT-induced activation of RIG-I and MDA5 in the innate antiviral response.
Siu KL; Yeung ML; Kok KH; Yuen KS; Kew C; Lui PY; Chan CP; Tse H; Woo PC; Yuen KY; Jin DY
J Virol; 2014 May; 88(9):4866-76. PubMed ID: 24522921
[TBL] [Abstract][Full Text] [Related]
7. Interaction of SARS and MERS Coronaviruses with the Antiviral Interferon Response.
Kindler E; Thiel V; Weber F
Adv Virus Res; 2016; 96():219-243. PubMed ID: 27712625
[TBL] [Abstract][Full Text] [Related]
8. Molecular Dynamic Studies of Interferon and Innate Immunity Resistance in MERS CoV Non-Structural Protein 3.
Alfuwaires M; Altaher A; Kandeel M
Biol Pharm Bull; 2017; 40(3):345-351. PubMed ID: 28250277
[TBL] [Abstract][Full Text] [Related]
9. UBR5 Acts as an Antiviral Host Factor against MERS-CoV via Promoting Ubiquitination and Degradation of ORF4b.
Zhou Y; Zheng R; Liu D; Liu S; Disoma C; Li S; Liao Y; Chen Z; Du A; Dong Z; Zhang Y; Liu P; Razzaq A; Chen D; Chen X; Zhong X; Liu S; Tao S; Liu Y; Xu L; Deng X; Li J; Jiang T; Zhao J; Li S; Xia Z
J Virol; 2022 Sep; 96(17):e0074122. PubMed ID: 35980206
[TBL] [Abstract][Full Text] [Related]
10. Middle East respiratory syndrome coronavirus: another zoonotic betacoronavirus causing SARS-like disease.
Chan JF; Lau SK; To KK; Cheng VC; Woo PC; Yuen KY
Clin Microbiol Rev; 2015 Apr; 28(2):465-522. PubMed ID: 25810418
[TBL] [Abstract][Full Text] [Related]
11. Innate immune evasion by SARS-CoV-2: Comparison with SARS-CoV.
Bouayad A
Rev Med Virol; 2020 Nov; 30(6):1-9. PubMed ID: 32734714
[TBL] [Abstract][Full Text] [Related]
12. Host Factors in Coronavirus Replication.
de Wilde AH; Snijder EJ; Kikkert M; van Hemert MJ
Curr Top Microbiol Immunol; 2018; 419():1-42. PubMed ID: 28643204
[TBL] [Abstract][Full Text] [Related]
13. Innate immune sensing of coronavirus and viral evasion strategies.
Kasuga Y; Zhu B; Jang KJ; Yoo JS
Exp Mol Med; 2021 May; 53(5):723-736. PubMed ID: 33953325
[TBL] [Abstract][Full Text] [Related]
14. A Kinome-Wide Small Interfering RNA Screen Identifies Proviral and Antiviral Host Factors in Severe Acute Respiratory Syndrome Coronavirus Replication, Including Double-Stranded RNA-Activated Protein Kinase and Early Secretory Pathway Proteins.
de Wilde AH; Wannee KF; Scholte FE; Goeman JJ; Ten Dijke P; Snijder EJ; Kikkert M; van Hemert MJ
J Virol; 2015 Aug; 89(16):8318-33. PubMed ID: 26041291
[TBL] [Abstract][Full Text] [Related]
15. Middle East Respiratory Coronavirus Accessory Protein 4a Inhibits PKR-Mediated Antiviral Stress Responses.
Rabouw HH; Langereis MA; Knaap RC; Dalebout TJ; Canton J; Sola I; Enjuanes L; Bredenbeek PJ; Kikkert M; de Groot RJ; van Kuppeveld FJ
PLoS Pathog; 2016 Oct; 12(10):e1005982. PubMed ID: 27783669
[TBL] [Abstract][Full Text] [Related]
16. The molecular virology of coronaviruses.
Hartenian E; Nandakumar D; Lari A; Ly M; Tucker JM; Glaunsinger BA
J Biol Chem; 2020 Sep; 295(37):12910-12934. PubMed ID: 32661197
[TBL] [Abstract][Full Text] [Related]
17. The Immune Responses against Coronavirus Infections: Friend or Foe?
Vafaeinezhad A; Atashzar MR; Baharlou R
Int Arch Allergy Immunol; 2021; 182(9):863-876. PubMed ID: 33951640
[TBL] [Abstract][Full Text] [Related]
18. Type I IFNs: A Blessing in Disguise or Partner in Crime in MERS-CoV-, SARS-CoV-, and SARS-CoV-2-Induced Pathology and Potential Use of Type I IFNs in Synergism with IFN-
Anjum FR; Anam S; Abbas G; Mahmood MS; Rahman SU; Goraya MU; Abdullah RM; Luqman M; Ali A; Akram MK; Chaudhry TH
Viral Immunol; 2021 Jun; 34(5):321-329. PubMed ID: 33181057
[TBL] [Abstract][Full Text] [Related]
19. Broad-spectrum antiviral GS-5734 inhibits both epidemic and zoonotic coronaviruses.
Sheahan TP; Sims AC; Graham RL; Menachery VD; Gralinski LE; Case JB; Leist SR; Pyrc K; Feng JY; Trantcheva I; Bannister R; Park Y; Babusis D; Clarke MO; Mackman RL; Spahn JE; Palmiotti CA; Siegel D; Ray AS; Cihlar T; Jordan R; Denison MR; Baric RS
Sci Transl Med; 2017 Jun; 9(396):. PubMed ID: 28659436
[TBL] [Abstract][Full Text] [Related]
20. Human coronaviruses 229E and OC43 replicate and induce distinct antiviral responses in differentiated primary human bronchial epithelial cells.
Loo SL; Wark PAB; Esneau C; Nichol KS; Hsu AC; Bartlett NW
Am J Physiol Lung Cell Mol Physiol; 2020 Dec; 319(6):L926-L931. PubMed ID: 32903043
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
